Emtricitabine / tenofovir alafenamide Alternatives Compared
| Emtricitabine / tenofovir alafenamide | Truvada (emtricitabine / tenofovir disoproxil) | Descovy (emtricitabine / tenofovir alafenamide) |
|
|---|
| Emtricitabine / tenofovir alafenamide | Truvada (emtricitabine / tenofovir disoproxil) | Descovy (emtricitabine / tenofovir alafenamide) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Pre-Exposure Prophylaxis, HIV Infection. Emtricitabine / tenofovir alafenamide may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pre-Exposure Prophylaxis, Occupational Exposure, HIV Infection, Nonoccupational Exposure. Truvada may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pre-Exposure Prophylaxis, HIV Infection. Descovy may also be used for purposes not listed in this medication guide. |
Related suggestions Pre-Exposure Prophylaxis
|
|||||||||||||||||||||||
| More about Emtricitabine / tenofovir alafenamide | More about Truvada (emtricitabine / tenofovir disoproxil) | More about Descovy (emtricitabine / tenofovir alafenamide) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Emtricitabine / tenofovir alafenamide has an average rating of 6.9 out of 10 from a total of 19 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 22% reported a negative effect. |
Truvada has an average rating of 6.4 out of 10 from a total of 39 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 29% reported a negative effect. |
Descovy has an average rating of 6.9 out of 10 from a total of 19 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
|
View all Truvada prices |
View all Descovy prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Descovy | Other emtricitabine / tenofovir disoproxil brands include: AccessPak for HIV PEP Basic |
N/A |
||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
25.7 hours |
25.7 hours |
25.7 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 240 drugs are known to interact with Emtricitabine / tenofovir alafenamide:
|
A total of 240 drugs are known to interact with Truvada:
|
A total of 240 drugs are known to interact with Descovy:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
April 04, 2016 |
August 02, 2004 |
April 04, 2016 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.